%0 Journal Article
%T Integrated Pharmacy Research and Practice
%A Todd A
%A Ling J
%J Integrated Pharmacy Research and Practice
%D 2012
%I 
%R http://dx.doi.org/10.2147/IPRP.S30272
%X Integrated Pharmacy Research and Practice Editorial (1342) Total Article Views Authors: Todd A, Ling J Published Date June 2012 Volume 2012:1 Pages 1 - 2 DOI: http://dx.doi.org/10.2147/IPRP.S30272 Received: 24 April 2012 Accepted: 24 April 2012 Published: 29 June 2012 Adam Todd,1 Jonathan Ling2 1Wolfson Research Institute, School of Medicine and Health, Queen¡¯s Campus, Durham University, Stockton-on-Tees, UK; 2Faculty of Applied Sciences, University of Sunderland, Sunderland, UK By 2014, the worldwide annual spend on medicines is expected to exceed one trillion dollars, representing an increase of nearly 90% since 2005.1 Thanks to modern medicine and the expanding number of pharmaceutical agents used to treat a wide range of diseases, average life expectancy is also set to increase, with, for example, average life expectancy in the UK increasing to 80 years of age, which is eight years higher than in the 1970s.2 However, despite this success, people around the world fail to use their medicines as they should, with a recent report by the World Health Organization estimating that, in developed countries, around 50% of patients are noncompliant with their long-term medication.3 In developing countries, this percentage is even higher, which is of particular concern because infectious diseases, such as human immunodeficiency virus and tuberculosis, are spreading rapidly. In view of this, the concept of "pharmaceutical care" has been introduced, and is defined as "the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve (or maintain) a patient¡¯s quality of life".4 Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Drug design with Cdc7 kinase: a potential novel cancer therapy target Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study Chronicles of a primary care practice pharmacist Potential role of rivaroxaban in patients with acute coronary syndrome Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease? Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion
%K Integrated Pharmacy Research and Practice Editorial (1342) Total Article Views Authors: Todd A
%K Ling J Published Date June 2012 Volume 2012:1 Pages 1 - 2 DOI: http://dx.doi.org/10.2147/IPRP.S30272 Received: 24 April 2012 Accepted: 24 April 2012 Published: 29 June 2012 Adam Todd
%K 1 Jonathan Ling2 1Wolfson Research Institute
%K School of Medicine and Health
%K Queen¡¯s Campus
%K Durham University
%K Stockton-on-Tees
%K UK
%K 2Faculty of Applied Sciences
%K University of Sunderland
%K Sunderland
%K UK By 2014
%K the wor
%U https://www.dovepress.com/integrated-pharmacy-research-and-practice-peer-reviewed-article-IPRP